The European Union's Environment, Public Health, and Food Safety Committee recently announced its support for innovative legislation designed to attract pharmaceutical investment, foster innovation, and make medicines more affordable, such as orphan drugs, antimicrobials, and vaccines.
The new reform would provide regulatory data protection to pharma companies for at least seven and a half years, during which competitors would have no access to their product data.
Read More
